Stockreport

Capnia Completes Merger with Essentialis Creating Rare Disease Therapeutics Company

CAPNIA  (CAPN) 
US:NASDAQ Investor Relations: investors.soleno.life/investor-overview
PDF Lead Clinical Asset Entering Phase II/III Development in 2017 for the Treatment of Prader-Willi Syndrome Raises $10 Million in Concurrent Financing; Cash Runway Through [Read more]